Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model

Fig. 4

A. PKH-26 labeling of hUC-MSC exosomes taken up by RAW264.7 cells. Scale barā€‰=ā€‰20Ā Ī¼m. B. Oil red O staining of foamy RAW264.7 cells (left panel). (a) Without any treatment; (b) Ox-LDL treatment for 48Ā h; (c) Ox-LDL treatment for 48Ā h after control medium (CM) extract treatment for 24Ā h; d. Ox-LDL treatment for 48Ā h after UC-MSC treatment for 24Ā h. Three fields were randomly selected to calculate the number of red lipid droplets and the number of cells. The fold change is shown by the histogram (right panel). C. Quantitative PCR results showing the endogenous mRNA levels of TNF-Ī±, IL-6 and IL-1Ī² in RAW264.7 cells. CM represents control medium extract treatment, and Ex represents UC-MSC exosome treatment. The independent experiment has been repeated for three times. *pā€‰<ā€‰0.05; **pā€‰<ā€‰0.01. D. Detection of the M2 polarization markers CD206, Arginase-1 and IL-10 in Ox-LDL-treated RAW264.7 cells by quantitative PCR. CM represents control medium extract treatment, and Ex represents UC-MSC exosome treatment. GAPDH mRNA served as reference standard. *pā€‰<ā€‰0.05; **pā€‰<ā€‰0.01

Back to article page